An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Current opinion in nephrology and hypertension

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00041552-199811000-00007PMID 9864663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGF-beta type II receptor in rat renal vascular development: localization to juxtaglomerular cells.

  1998cited by this paper
• Evidence for TGF-β-Mediated ‘Defense’ of the Glomerulus: A Blackguard Molecule Rehabilitated?

  1998cited by this paper
• Increased mortality, blunted production of nitric oxide, and increased production of TNF-alpha in endotoxemic TGF-beta1 transgenic mice.

  1998cited by this paper
• Differential Effects of Transforming Growth Factor-β on the Expression of Collagenase-1 and Collagenase-3 in Human Fibroblasts*

  1998cited by this paper
• Transforming Growth Factor-β Stimulates Interleukin-11 Transcription via Complex Activating Protein-1-dependent Pathways*

  1998cited by this paper
• TGF-?? AND ANTI-TGF-?? REVERSES THE ANTI-PROLIFERATIVE EFFECTS OF CYCLOSPORINE IN VIVO

  1998cited by this paper
• Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat.

  1998cited by this paper
• Endothelin: new discoveries and rapid progress in the clinic.

  1998cited by this paper
• Angiotensin II and gene expression in the kidney.

  1998cited by this paper
• Documentation of angiotensin II receptors in glomerular epithelial cells.

  1998cited by this paper
• Transforming growth factor-β1 regulates chemokine and complement production by human proximal tubular epithelial cells

  1998cited by this paper
• Increased mortality, blunted production of nitric oxide, and increased production of TNF‐α in endotoxemic TGF‐β1 transgenic mice

  1998cited by this paper
• Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.

  1998cited by this paper
• Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

  1998cited by this paper
• RAPAMYCIN (RAPA) ENHANCES TRANSFORMING GROWTH FACTOR BETA(TGF-β1) EXPRESSION IN IMMORTALIZED RAT PROXIMAL TUBULES CELLS(IRPTC).

  1998cited by this paper
• DIRECT EFFECT OF HUMAN TRANSFORMING GROWTH FACTOR-β1 ON ALBUMIN PERMEABILITY OF RAT GLOMERULI IN VITRO.

  1998cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• Does cyclosporin promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation?

  1998cited by this paper
• Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways.

  1998cited by this paper
• Interaction between high glucose and TGF-beta in cell cycle protein regulations in MDCK cells.

  1998cited by this paper
• TGF-β MIMICS AND ANTI-TGF-β REVERSES THE FIBROGENIC AND NEPHROTOXIC EFFECTS OF CYCLOSPORINE

  1998cited by this paper
• Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression.

  1998cited by this paper
• DECREASED EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA (TGF-β) IN BIOPSIES WITH CHRONIC ALLOGRAFT NEPHROPATHY AFTER ONE YEAR OF 50% CYCLOSPORINE LEVEL REDUCTION AND MYCOPHENOLATE ADDITION

  1998cited by this paper
• THE RATE OF DECLINE IN RENAL FUNCTION IN CHRONIC ALLOGRAFT REJECTION(FIBROSIS) CAN BE PREDICTED BY INTRATUBULAR LEVELS OF TRANSFORMING GROWTH FACTOR BETA (TGFβ)

  1998cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• TGF-beta: a link between immunosuppression, nephrotoxicity, and CsA.

  1998cited by this paper
• Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells.

  1998cited by this paper
• TGF-β: A Link Between Immunosuppression, Nephrotoxicity, and CsA

  1998cited by this paper
• TGF-beta1 as an endogenous defender against macrophage-triggered stromelysin gene expression in the glomerulus.

  1998cited by this paper
• Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.

  1998cited by this paper
• Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.

  1997cited by this paper
• The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.

  1997cited by this paper
• Transforming growth factor-beta in human glomerular injury.

  1997cited by this paper
• Structural organization and chromosomal assignment of the swine endothelin-1 gene.

  1997cited by this paper
• Transforming growth factor-β in human glomerular injury

  1997cited by this paper
• Cyclosporine A-induced contraction of isolated rat aortic smooth muscle cells.

  1997cited by this paper
• Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats.

  1997cited by this paper
• Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients.

  1997cited by this paper
• Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts.

  1997cited by this paper
• Endothelin in ischemic acute renal failure

  1997cited by this paper
• Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells.

  1997cited by this paper
• Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse.

  1997cited by this paper
• The AP-1 site and MMP gene regulation: what is all the fuss about?

  1997cited by this paper
• Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression.

  1997cited by this paper
• Sirolimus, a New, Potent Immunosuppressive Agent

  1997cited by this paper
• Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney.

  1997cited by this paper
• Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells

  1997cited by this paper
• Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.

  1997cited by this paper
• In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine.

  1997cited by this paper
• Angiotensin-Converting Enzyme Inhibition Decreases Growth Factor Expression in the Neonatal Rat Kidney

  1997cited by this paper
• Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.

  1997cited by this paper
• Transcription Factor Egr-1 Regulates Glomerular Mesangial Cell Proliferation*

  1996cited by this paper
• Cyclosporin A induces transcription of transforming growth factor beta in a cultured murine proximal tubular cell line.

  1996cited by this paper
• Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

  1996cited by this paper
• An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta.

  1996cited by this paper
• An AP-1 Binding Sequence Is Essential for Regulation of the Human 2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor- (*)

  1996cited by this paper
• Endogenous Insulin Modulates Circulating Endothelin-1 Concentrations in Humans

  1996cited by this paper
• Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels.

  1996cited by this paper
• Endothelin antagonists on the clinical horizon in nephrology.

  1996cited by this paper
• Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.

  1996cited by this paper
• Roles of calcium and kinases in regulation of thrombin-stimulated preproendothelin-1 transcription.

  1996cited by this paper
• Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth.

  1995cited by this paper
• TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells.

  1995cited by this paper
• Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene

  1995cited by this paper
• Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney.

  1995cited by this paper
• Mapping the Domain(s) Critical for the Binding of Human Tumor Necrosis Factor-α to Its Two Receptors (*)

  1995cited by this paper
• Transforming growth factors beta stimulate both thrombospondin-1 and CISP/thrombospondin-2 synthesis by bovine adrenocortical cells.

  1995cited by this paper
• Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes.

  1995cited by this paper
• Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*)

  1995cited by this paper
• Stimulation of transforming growth factor‐β 1 transcription by cyclosporine

  1995cited by this paper
• Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element in PC12 cells.

  1994cited by this paper
• Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.

  1994cited by this paper
• Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.

  1994cited by this paper
• Binding of AP-1/CREB proteins and of MDBP to contiguous sites downstream of the human TGF-beta 1 gene.

  1994cited by this paper
• Transforming growth factor-beta is a renin secretagogue at picomolar concentrations.

  1993cited by this paper
• Endothelins--from receptors to medicine.

  1993cited by this paper
• Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes

  1993cited by this paper
• Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression.

  1991cited by this paper
• Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype.

  1991cited by this paper
• Regulation of endothelin-1 gene expression by Fos and Jun.

  1991cited by this paper
• Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes

  1990cited by this paper
• Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence.

  1990cited by this paper
• Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function.

  1990cited by this paper
• Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.

  1987cited by this paper
• Cyclosporine-associated chronic nephropathy.

  1984cited by this paper
• Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.

  1984cited by this paper

• Animal models and natural products to investigate in vivo and in vitro antidiabetic activity.

  2018cites this paper
• Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with cyclosporine-induced nephrotoxicity.

  2010cites this paper
• Nephrotoxicity of calcineurin and mTOR inhibitors

  2008cites this paper
• Immunosuppression in the past and today

  2005cites this paper
• Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.

  2005cites this paper
• Chronic cyclosporine nephrotoxicity in renal transplantation

  2004cites this paper
• Cyclosporine enhances salt sensitivity of body water composition as assessed by impedance among psoriatic patients with normal renal function.

  2004cites this paper
• The effect of rapamycin after cyclosporin dose reduction on chronic allograft nephropathy

  2003cites this paper
• Beneficial effect of losartan against proteinuria from the renal allograft.

  2003cites this paper
• Calcineurin inhibitors and sirolimus

  2003cites this paper
• Nephrotoxicity of immunosuppressive agents in renal transplantation

  2002cites this paper
• Comparative Tolerability of Systemic Treatments for Plaque-Type Psoriasis

  2002cites this paper
• Endothelin and Its Inhibitors

  2001cites this paper
• The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.

  2001cites this paper
• Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.

  2001cites this paper
• CYCLOSPORINE INDUCES MYOCARDIAL CONNECTIVE TISSUE GROWTH FACTOR IN SPONTANEOUSLY HYPERTENSIVE RATS ON HIGH-SODIUM DIET1

  2001cites this paper
• Safety of the new macrolide immunomodulators.

  2001cites this paper
• Tailoring immunosuppressive therapy for renal transplant recipients

  2001cites this paper
• Néphrotoxicité des traitements immunosuppresseurs utilisés en transplantation rénale

  2001cites this paper
• Transcriptional Induction of Endothelial Nitric Oxide Gene by Cyclosporine A

  2000cites this paper
• Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.

  2000cites this paper
• The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth.

  2000cites this paper
• MECHANISMS OF NEPHROTOXICITY

  2000cites this paper
• Combined effects of AT1 and ETA receptor antagonists, candesartan, and A-127722 in DOCA–salt hypertensive rats

  2000cites this paper
• Dialysis and transplantation.

  1999cites this paper
• Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?

  1999cites this paper